Application challenges of the new EU Clinical Trials Regulation

被引：0
|
作者：
Eugenijus Gefenas
Asta Cekanauskaite
Jurate Lekstutiene
Vilma Lukaseviciene
机构：
[1] Medical Faculty of Vilnius University,Department of Medical History and Ethics
[2] Lithuanian Bioethics Committee,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Research ethics; Ethics committees; Clinical drug trials; Clinical Trials Regulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 798
页数：3
相关论文
共 50 条
  • [21] Simple, Safe And Transparent(?): Preliminary Reflections on the Proposal for a New EU Regulation of Clinical Trials
    Rizzi, Marco
    EUROPEAN JOURNAL OF RISK REGULATION, 2013, 4 (04) : 534 - 538
  • [22] Not at all simple: The lay language summary of oncology clinical trials results. Challenges in implementing the new EU regulation (536/2014)
    Nottbohm, A.
    Weiss-Haljiti, C.
    Schindler, T. M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Simplified consent in cluster randomised trials: the new EU Clinical Trials Regulation does not provide sufficient guidance
    Goldstein, Cory E.
    van der Graaf, Rieke
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
  • [24] The new EU clinical trials directive -: Response
    Koelch, M.
    Schubert, S.
    Lippert, H.-D.
    Fegert, J. M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (06) : 564 - 564
  • [25] Clinical trials with investigational medicinal products-initial experiences with the new EU clinical trial regulation 536/2014 and challenges and opportunities for contract research organisations
    Chase, Dagmar
    Roder, Beate
    Matuschek, Iris Romero
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2023, 66 (01) : 21 - 27
  • [26] Will the EU clinical trials regulation support the innovative industry in bringing new medicines faster to patients?
    Atzor S.
    Gokhale S.
    Doherty M.
    Pharmaceutical Medicine, 2013, 27 (2) : 75 - 82
  • [27] REGULATION (EU) NO 536/2014 ON CLINICAL TRIALS AND VULNERABLE GROUPS
    Marino Hernandez, Eduardo L.
    CUADERNOS DE BIOETICA, 2015, 26 (88): : 427 - 430
  • [28] Accelerating clinical trials in the EU (ACT EU): transforming the EU clinical trials landscape
    Capone, Giacomo
    Eriksson, Bjoern
    Al, Monique
    van Belkum, Stan
    Broich, Karl
    Lamas, Maria
    Lunzer, Marianne
    Nolan, Lorraine
    Ester, Catriona
    Burgos, Juan Garcia
    Pioppo, Laura
    Zanoletty, Ana
    Arlett, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (11) : 797 - 798
  • [29] The European clinical trials regulation (No 536/2014): changes and challenges
    Scavone, Cristina
    di Mauro, Gabriella
    Pietropaolo, Michela
    Alfano, Roberto
    Berrino, Liberato
    Rossi, Francesco
    Tomino, Carlo
    Capuano, Annalisa
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (11) : 1027 - 1032
  • [30] Principles of the EU Clinical Trials Regulation No 536/2014 What will change?
    Mende, Aylin
    Frech, Marion
    Riedel, Claudia
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (08) : 795 - 803
12345